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Type 2 antigens such as polyvinylpyrrolidone (PVP), 1 type III pneumococcal 
polysaccharide ($3), and dinitrophenyl  (DNP)-ficoll characteristically elicit anti- 
body responses in mice that consist almost entirely of antibodies of the IgM and 
IgG3 isotypes (1-4). Type 2 antigens also are generally unable to prime mice to 
produce I gG 1 and IgG2 antibodies after secondary challenge, i.e. they are unable 
to prime for IgG memory responses (2,  5-8).  The inability of these antigens to 
prime mice for IgG memory responses is presumably due, at least in part, to the 
fact that type 2 antigens generally do not activate antigen-specific helper T  cells 
(Th), which have been shown (5, 9-14) to be required for the differentiation of 
B cells to IgG-producing  memory B cells.  For example,  previous studies from 
this laboratory (5, 6,  14) showed that the type 2 antigen $3 could prime for IgG 
memory responses  only  if $3  was coupled  to  a  carrier,  horse  red  blood cells 
(HRBC),  which  could activate  Th.  These activated Th  were required  for the 
differentiation of B cells to IgG-producing B memory cells. In subsequent studies 
using PVP as antigen,  it was shown (15,  16) that very low doses (0.0025 #g) of 
this  type  2  antigen  could  prime  mice  for  IgG  memory  responses  nearly  as 
effectively as a  thymus-dependent  (TD) form of PVP: PVP coupled to HRBC. 
By contrast, higher doses of PVP could not induce IgG memory responses; these 
amounts of PVP actually interferred with the induction of memory cells by PVP- 
HRBC (15).  Consistent with the premise that activation of Th was required to 
prime B memory cells, it was further shown (15,  16) that the low dose of PVP 
activated Th, while higher doses did not. 
This study further examines the requirements  for activation of Th by PVP. 
The results indicate that higher doses of PVP can activate PVP-specific Th, but 
that these Th can only be detected when suppressor T  cells (Ts) are eliminated. 
Thus, very low doses of PVP preferentially activate Th, whereas higher doses of 
PVP activate both Th and Ts, and the activity of the latter cells predominate in 
whole T  cell populations. The implications of these findings for induction of IgG 
responses to type 2 antigens will be discussed. 
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Materials and Methods 
Mice.  CAFI (BALB/c × A/J Fl) female mice were used for all experiments. They were 
obtained from The Jackson Laboratories, Bar Harbor, ME and were 8-10 wk old at the 
time of priming. 
Antigens.  PVP  (360  kilodaltons  [kD])  was  purchased  from  Aldrich  Chemical  Co., 
Milwaukee, WI. This antigen has been shown to behave as a typical type 2 antigen, in 
that it elicits antibody that is primarily of the IgM isotype, is immunogenic in both athymic 
nude and euthymic mice (1, 2), and does not induce antibody responses in CBA/N (xid) 
mice (my unpublished results). A TD form of PVP was prepared as previously described 
(15) by coupling 360 kD PVP to HRBC. 
Priming  of Donor Mice.  An  adoptive transfer system  was  used  for all  experiments 
because  this  was  shown  in  preliminary  experiments  to  result  in  higher  PVP-specific 
memory responses than are observed in the intact animal (15).  Mice to be used as B cell 
donors were primed intravenously 2-5 mo before cell transfer with 2 ×  108 PVP-HRBC. 
T  cell donors were either not primed (normal T) or were primed 2-3 mo before cell 
transfer with 0.0025, 0.25, or 25 #g PVP. These doses of PVP are marginally immuno- 
genic (0.0025 t,g), optimal (0.25/~g), or supraoptimal (25 ttg) in terms of their ability to 
elicit primary IgM antibody responses in CAFI mice (2) (Table II). For some experiments, 
mice to be used as T cell donors were given 100 mg/kg cyclophosphamide (CY) (Cytoxan, 
Mead Johnson & Co., Indianapolis, IN) 2 d before priming. 
Adoptive Transfer and Secondary Challenge.  Mice to be used as recipients of primed 
cells were irradiated (700 rad) at the 6°Co facility at the University of Missouri-Columbia 
Research Reactor. Within 6 h of irradiation, mice were repopulated with B cells alone 
(1-1.4 ×  107 cells/mouse) or with B cells plus 4-6 ×  106 T  cells.  Mice were immunized 
immediately after cell transfer with 2 ×  108 PVP-HRBC (15).  B cells were prepared by 
treating spleen cells from PVP-HRBC-primed mice with monoclonal anti-Thy-l.2 (HO 
13.4) antibody and complement (C), as previously described (5, 14). T cells were obtained 
from normal or PVP-primed mice by passage through nylon wool, as previously described 
(5,  14). In some experiments, the nylon wool-nonadherent cells were treated with anti- 
Lytol.2 or anti-Lyt-2.2 and C before transfer (17). 
Plaque-forming cell (PFC) Assay.  PVP-specific PFC were counted 7 d after challenge of 
recipient mice using  PVP-SRBC as  indicator erythrocytes (15).  All  spleens were also 
assayed  with  unconjugated  SRBC,  and  PFC  detected  with  SRBC  (usually  <800 
PFC/spleen) were subtracted from PFC detected with PVP-SRBC.  Both IgM and IgG 
PFC were determined in these experiments as previously described (15). 
Results 
Activation  of Th by PVP Is Antigen-dose-dependent.  As  shown  in  Table  I,  T 
cells from mice primed with a  low dose (0.0025 ~g) of PVP are able to provide 
significant help to B cells from PVP-HRBC-primed mice for production of PVP- 
specific IgG.  In contrast,  T  cells from normal mice or from mice primed with 
higher doses (0.25  or 25/~g) of PVP provide little,  if any, help to the same  B 
cells. The helper activity of the low-dose PVP-primed T  cells is comparable to 
helper activity provided by T  cells from mice primed with PVP-HRBC (16 and 
my  unpublished  results).  As  shown  previously (15),  T  cells  generally provide 
some  help  to  B  cells  for production  of IgM,  especially in  Exp.  2  of Table  I. 
However, the level of help for IgM  is similar whether or not the T  cells have 
been  primed  with  PVP.  Therefore,  for  simplicity,  only the  PVP-specific  IgG 
responses will  be shown  in  the  majority of the  studies  to be described below. 
PVP-specific IgG responses are not observed when primed Th are added to B 
cells from normal mice or mice primed with 0.25 #g PVP, but B cells from mice 
primed with 0.0025/~g PVP are nearly as effective as B cells from mice primed BRALEY-MULLEN  1359 
Exp. 
TABLE  I 
Low Doses of PVP Activate Th Required  for Production of 
PVP-specific lgG 
T cell donors 
primed with:* 
PVP-specific  PFC/spleen* 
IgM  IgG 
No T cells  1,007 + 203  1,207 _  217 
Nothing  1,259 ___ 198  1,717 ± 268 
0.25 #g PVP  1,588 ±  102  1,341 ± 378 
0.0025 #g PVP  1,400 +  163  6,725 ±  395 
No T cells  1,163 +  153  2,113 +  1,019 
Nothing  3,825 _  257  5,533 +  376 
25 #g PVP  3,375 ±  118  2,300 _  435 
0.0025 t~g PVP  2,025 ± 255  18,330  +_ 4,859 
* Irradiated CAFI mice received 1.3 ×  l0  T B cells (anti-Thy-l.2-treated 
spleen cells) from donors primed with PVP-HRBC.  Mice received, in 
addition, no T  cells or 5 ×  106 T  cells (nylon wool-passed spleen cells) 
from normal mice or from mice primed 2-3 mo earlier with the indicated 
amounts of PVP. All mice were immunized with PVP-HRBC. 
* Mean PVP-specific PFC/spleen __SEM (4-5 mice/group) determined 7 
d after immunization. 
TABLE  II 
Induction of  Primary Antibody Responses with Various Amounts of 
PVP 
Antigen dose*  PVP-specific IgM PFC/spleen* 
ug 
0.0025  1,663 -  91 
0.025  5,075 + 2,384 
0.25  23,825 +  1,348 
2.5  19,800 + 4,183 
25  16,875  __. 2,440 
* Groups of 4  CAF~ mice were  immunized  intraperitoneally with  the 
indicated amounts of PVP. 
~; Mean  PFC/spleen +SEM.  IgM PFC/spleen determined 5 d  after im- 
munization. IgG PFC were negligible (<I,000 PFC/spleen) in all groups. 
with  PVP-HRBC  (15,  16  and  my  unpublished  results).  The  low  dose  of PVP 
(0.0025  #g) that activates Th  and primes memory  IgG-producing  B  cells is only 
marginally immunogenic  for  induction  of primary  IgM  antibody  responses  in 
CAF1  mice (Table  II).  In  contrast,  0.25  #g  PVP  induces optimal primary  IgM 
responses, while 25 t~g PVP is supraoptimal but also induces an excellent primary 
response (Table II). No appreciable IgG is produced  after primary immunization 
with any of these doses of PVP (not shown). Thus  PVP-specific Th  are activated 
by doses  of PVP  that  are  suboptimal  for  induction  of primary  anti-PVP  IgM 
responses. 
High Doses of  PVP Activate Ts that Suppress PVP-specific IgG Responses.  Having 
shown  that  0.25  and  25  t~g  PVP  are  unable  to activate Th  (Table  I), the  next 
step was  to  determine  whether  T  cells from  these  mice  were  able to  suppress 
PVP-specific  secondary  responses.  As  shown  in  Fig.  1,  recipient  mice  given 1360  HELPER  AND  SUPPRESSOR  T  CELL  ACTIVATION BY  PVP 
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FIGURE 1.  Suppression of PVP-specific IgG responses by T cells from mice primed with 0.25 
#g PVP. Irradiated CAF, mice were repopulated with 1.2 x  107 B cells (anti-Thy-l.2  and C- 
treated spleen cells) from CAFI donors primed 3 mo earlier with PVP-HRBC. Groups A and 
F received no additional cells; other groups received B cells plus 5 ×  108 T cells (nylon wool- 
passed spleen cells) from normal CAF~ mice (B) or from CAF1 mice primed 2 mo earlier with 
0.25 or 0.0025 ~g PVP. Groups E, H, and I received 5 x  106 of each of the indicated sources 
of T cells. All mice were immunized with 2 X 108 PVP-HRBC, and PVP-specific PFC were 
determined  7  d  later.  Results are  expressed  as  mean  IgG  PFC/spleen  +SEM of 4-5 
mice/group.  The mean group IgM PFC responses ranged from 1,125 _+ 112 PFC/spleen (A) 
to 1,710 + 365 PFC/spleen (E) in the first experiment, and from 1,713 _+ 172 PFC/spleen (F) 
to 3,540 _+ 772 PFC/spleen (I) in the second experiment. 
primed  B  cells  and  Th  cells  from  mice  primed  with  0.0025  #g  PVP  (Fig.  1, 
groups D  and G) again produced  much more PVP-specific IgG than mice given 
B cells and normal T  cells or T  cells from mice primed with 0.25  ~g PVP (Fig. 
1, groups B, C, and F).  Mice receiving B cells plus a  mixture of low-dose PVP- 
primed Th and T  cells from high-dose PVP-primed  mice (Fig.  1, groups E and 
H) also had much lower IgG responses; T  cells from the high-dose-primed mice 
apparently suppressed the  IgG antibody responses.  Suppression  was dependent 
on prior priming of the T  cell donors  with  0.25  ~g or more of PVP,  since an 
equivalent  number  of normal  T  ceils  (Fig.  I,  group  I)  or  T  cells  from  mice 
primed with  $3  or  0.0025  ~g PVP  (data not  shown)  had  no effect on the  IgG 
responses. The suppression  induced by priming with PVP is long-lasting;  in the 
experiments  shown  in  Fig.  1,  cells  were  from  mice primed  2  mo earlier  with 
PVP,  and  other  experiments  (not  shown)  have  shown  that  T  cells  still  have 
suppressor  activity  at  least  7  mo  after  priming  with  0.25  /~g  PVP.  As  stated 
earlier,  the  IgM  responses  of all  mice that  received  T  cells,  in  this and  other 
experiments, varied by less than twofold (also see Table III). Thus, the suppressor 
cells  induced  by  high  doses  of PVP  selectively  suppress  PVP-specific  IgG  re- 
sponses. 
High Doses of PVP Can Activate Th in CY-treated  Mice.  The results in Table I 
and Fig.  1 indicate that high amounts of PVP (0.25  or 25 ~g) (see Figure  1 and 
Table  III) did  not  activate  detectable  PVP-specific  Th,  but  did,  apparently, 
activate Ts, which prevented the production of IgG by primed B cells and PVP- BRALEY-MULLEN 
TABLE  III 
Abrogation of Ts Activity by CY Pretreatment of PVP-primed T Cell Donors 
1361 
Group  T cells from mice primed with:* 
PVP-specific PFC/spleen* 
IgM  IgG 
A  No T  cells  1,038 +  180  263 -+ 74 
B  0.0025 t~g PVP  3,580 _+ 355  9,660 +  1,570 
C  25 #g PVP  2,425  +- 164  950 -+ 155 
D  0.0025 ug PVP + 25 ~g PVP  2,180 +- 222  1,600 + 515 
E  CY +  25 #g PVP  1,990 + 640  6,650  -  1,613 
F  0.0025 ug PVP + CY +  25 t~g PVP  4,075  -+. 805  9,438  +  1,116 
* Irradiated CAFt mice received 107 B cells from mice primed 3 mo earlier with PVP-HRBC.  Group 
A received no T cells, and Groups B, C, and E received 6 x  106 T cells from donors primed 3 mo 
earlier with 0.0025 or 25 #g PVP.  Groups D and F got 6 X 106 of each of the indicated T  cells. 
CY-treated donors (D-F) received 100 mg/kg CY 2 d before priming with 25 ~g PVP.  All mice 
were immunized with PVP-HRBC. 
* Mean PVP-specific PFC/spleen -+_SEM, determined 7 d after immunization (4-5 mice/group). 
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FIGURE 2.  Activation of PVP-specific Th by high doses of PVP in CY-treated mice. Irradiated 
CAFz mice were repopulated with  1.2 x  10  B cells (anti-Thy-l.2 and C-treated spleen cells) 
from mice primed 2.5  mo earlier with  2 x  108  PVP-HRBC.  Groups A and F  received no 
additional cells; all other groups received, in addition,  5 x  106 T  cells (nylon  wool-passed 
spleen) from CAF1 donors primed 3 mo earlier with the indicated amount of PVP. CY-treated 
donors (C, E, I, and K) were given 100 mg/kg CY 2 d before priming with  PVP.  All mice 
were immunized with PVP-HRBC, and PVP-specific PFC were determined 7 d later.  Results 
are expressed as mean PVP-specific  IgG PFC/spleen _+SEM for 4-5 mice/group. The mean 
group  IgM  PFC  responses  ranged  from  2,550  +  340  PFC]spleen  (A)  to  6,563  ___  2,017 
PFC/spleen (C) in the first experiment, and from 750 +_ 85  PFC/spleen (F) to 2,430  __+ 253 
(K) in the second experiment. 
specific Th. The  question then arose as to whether high amounts of PVP might 
be able to activate Th  that would provide help to primed B  cells if the activation 
of Ts were reduced. Some Ts precursors have been shown (17,  18) to be sensitive 
to  CY.  Therefore,  mice  were  given  100  mg/kg  CY  2  d  before priming  with 
0.0025,  0.25, or 25 t~g PVP.  2-3 mo Dater, T  cells from these mice were assessed 
for their ability to provide help to PVP-HRBC-primed  B  cells. As shown in Fig. 1362  HELPER  AND  SUPPRESSOR  T  CELL  ACTIVATION  BY  PVP 
2,  T  cells from low-dose PVP-primed mice again provided help to B cells for 
IgG responses (Fig. 2, groups B and G), and CY pretreatment did not affect the 
activity of these Th (Fig. 2, group C). As before, T  cells from mice primed with 
0.25 or 25 ~tg PVP had little Th activity (Fig. 2, groups D, H, and J). In contrast, 
T  cells from mice treated with  CY before priming with  0.25  #g PVP had as 
much Th activity as T  cells from low-dose PVP-primed mice (Fig.  2,  group B 
vs. group E, and group G vs. group I). CY-treated mice primed with a very high 
dose (25  ~tg) of PVP also had significant Th activity (Fig.  2,  group K).  These 
results suggest that CY might act to prevent the activation of Ts by high doses 
of PVP, thereby allowing Th to be activated. To provide more direct evidence 
for this hypothesis, T  cells from both normal and CY-treated mice given 25 ~tg 
PVP were assessed for their ability to suppress the responses induced by PVP- 
primed B cells and Th (Table III).  As before, T  cells from mice given 25  ~tg 
PVP (Table III, group C) provided only marginal help to B cells for IgG responses 
compared to T  cells from low-dose PVP-primed mice (Table III, group B). T 
cells from 25 ~g PVP-primed mice markedly suppressed the IgG response when 
transferred with low-dose PVP-primed Th (Table III, group D). In contrast, T 
cells from mice given CY before priming with 25 ~g PVP again had significant 
Th activity (Table III, group E), and these cells did not suppress the IgG response 
when mixed with low-dose PVP-primed Th (Table III, group F).  Thus, treat- 
ment of mice with  CY  before priming with  high  doses of PVP  prevents  the 
activation of Ts by PVP, and results in the activation of PVP-specific Th. 
Removal of  L  yt-2  + Cells Reveals Th Activity in High-dose PVP-primed T cells.  The 
results described above indicated that  PVP-specific Th  could be activated by 
high doses of PVP when mice were given CY at the time of priming to prevent 
Ts activation. To determine whether Ts activation by high doses of PVP actually 
prevented priming of Th, or whether the presence of Ts prevented detection of 
Th activity in these mice, T  cells from mice primed 2  mo earlier with either 
0.0025 or 0.25 #g PVP were treated with anti-Lyt-l.2 and C or anti-Lyt-2.2 and 
C before transfer (Fig. 3). The Th activity of low-dose PVP-primed T  cells was 
not affected by treatment with anti-Lyt-2.2 (Fig.  3, group D vs.  group B), but 
was completely eliminated by treatment of these cells with anti-Lyt-l.2 and C 
(Fig.  3 group C);  these Th are Lyt-l÷2  -  T  cells. As before, T  cells from mice 
primed with 0.25  t~g PVP had little Th activity (Fig.  3,  group E vs. group A). 
However, when these cells were treated with anti-Lyt-2.2 and C, the remaining 
(Lyt-1 +) T  cells had as much Th activity as low-dose PVP-primed T  cells (Fig. 
3, group F vs. groups B and D). Moreover, as might be expected, these anti-Lyt- 
2-treated cells no longer suppressed IgG responses when they were mixed with 
B cells and low-dose PVP-primed Th (data not shown). Thus, 0.25 ~tg PVP can 
activate both Th and Ts in normal mice, but Ts activity predominates, so that 
Th are detected only after Ts are eliminated. 
Discussion 
The results presented here demonstrate that  the type 2  antigen, PVP,  can 
activate Th that are required for the production of PVP-specific IgG by PVP- 
specific primed B cells. Priming of Th by PVP is most readily accomplished using 
a very low dose (0.0025 #g) of PVP (Table I), an amount that is only marginally BRALEY-MULLEN  1363 
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FIGURE 3.  Effect  of anti-Lyt and C treatment on the activity of T cells from mice primed 
with 0.0025 or 0.25 t~g PVP. Irradiated CAFI mice were repopulated with 1.2 X l0  T  B cells 
(anti-Thy-1.2 and C-treated spleen) from mice primed 4 mo earlier with PVP-HRBC. Group 
A received no additional cells; groups B-F received B cells plus 7 x  l0  s T cells (nylon wool- 
passed spleen) from mice primed 3.5 mo earlier with 0.0025 or 0.25 ug PVP. T cells were 
treated with C alone or with anti-Lyt-l.2 or anti-Lyt-2.2 and C, as indicated. All mice were 
immunized with PVP-HRBC, and PVP-specific PFC were determined 7 d later. Results are 
expressed as mean PVP-specific IgG PFC/spleen ±SEM of 8-10 mice/group (results of two 
separate experiments are pooled). The mean group IgM PFC/spleen ranged from 1,850 ± 
240 PFC/spleen (.4) to 3,910 ± 432 PFC/spleen (F). 
immunogenic for induction of primary PVP-specific IgM responses (Table  II). 
As previously described (15),  however, this low amount of PVP can effectively 
prime  B  cells  to  produce  IgG antibody after secondary  challenge  with  PVP- 
HRBC.  In contrast,  higher amounts of PVP  (0.25  ~g),  which induce optimal 
primary anti-PVP (IgM) responses (2) (Table II), do not prime B  cells for IgG 
production in a secondary response to PVP-HRBC (15), and this amount of PVP 
actually  interferes  with  the  development  of  IgG-producing  B  memory  cells 
induced by priming with PVP-HRBC (15). Moreover, T  cells from mice primed 
with 0.25 #g or higher amounts of PVP provided only minimal help to primed 
B cells for IgG production (Table I). 
The results of this study also establish that the inability of T  cells from mice 
primed with 0.25 or 25 ~g PVP to provide help for IgG production is due to the 
fact that these amounts of PVP activate T  cells that suppress IgG responses when 
they are transferred together with primed Th and B cells (Fig.  1 and Table III). 
However,  when  mice  are  given  CY  before  priming with  high doses of PVP, 
activation of Ts is prevented (Table III), and T  cells from these mice are able to 
provide excellent help to B cells for the production of IgG (Fig. 2).  Moreover, 
elimination of Ts by treatment of high-dose PVP-primed T  cells with anti-Lyt- 
2.2 and C  (Fig. 3) or 1,000-rad  irradiation (my unpublished results)just before 
transfer also eliminates Ts and enables these cells to provide help to B cells for 
IgG  responses.  Thus,  both  low and  higher doses of PVP  are  able  to activate 
PVP-specific Th, although priming with high doses of PVP  also results in the 
activation of Ts, the activity of which predominates and prevents the expression 
of Th function. 
There are several other recent reports in which an apparent absence of antigen- 
primed Th has been shown to be due to the presence of specific Ts that prevent 
the expression of Th activity. For example, Jensen  et al. (19) found that mice 1364  HELPER  AND  SUPPRESSOR  T  CELL  ACTIVATION  BY  PVP 
that are phenotypic nonresponders to pork insulin have pork insulin-specific Ts 
that  predominate and prevent expression of Th activity.  Similar observations 
have also been reported by Pierce et al.  (20) for phenotypic nonresponders to 
GAT (a polymer of glutamic acid, alanine, and tyrosine), by Baxevanis et al. (21) 
for nonresponders to  lactate dehydrogenase B,  and by Sercarz et al.  (22) for 
nonresponders to lysozyme. Thus, masking of functional Th by excess Ts may 
be the mechanism underlying phenotypic nonresponsiveness in at least some Ir 
gene-controlled responses and,  as shown here, may also explain  why at  least 
some type 2 antigens have not previously been found to activate specific Th. 
Previous studies from this as well as other laboratories (2,  5-8,  23,  24) have 
shown that the so-called thymus-independent or type 2 antigens are unable to 
prime mice for development of IgG memory responses.  The inability of such 
antigens to prime IgG-producing memory B cells has been attributed to the fact 
that type 2 antigens are unable to prime Th, which are needed for the differen- 
tiation  of B  cell precursors to  IgG-producing B  memory cells, since it is well 
established that TD forms of these same antigens both activate Th and prime 
memory B cells (5,  14,  15,  23). Moreover, as shown previously (15), a very low 
dose of the type 2 antigen, PVP, can prime mice for IgG memory responses, and 
this amount of PVP also activates PVP-specific Th that can interact with primed 
PVP-specific B cells to result in the production of PVP-specific IgG antibody (15, 
16) (Table I).  The fact that a  low dose of PVP can activate Th,  while higher 
doses do not (Table I), indicates that this type 2  antigen can activate antigen- 
specific Th, but that these Th can be detected only under defined conditions of 
immunization, where Ts activation is minimized or eliminated. 
These results establish for the first time that commonly employed, i.e., opti- 
mally immunogenic amounts of PVP activate Ts, which regulate the function of 
Th (Fig.  1). The Ts that are activated by immunogenic amounts of PVP appear 
to selectively suppress the IgG component of the antibody response (Table III), 
as opposed to  PVP-specific Ts activated by tolerogenic forms of PVP,  which 
suppress the IgM response (17, 28). The ability of PVP to activate Ts that mask 
the activity of the Th  needed for IgG  production  (8-13,  15,  29)  may be  an 
explanation for two general features that distinguish immune responses to type 
2  antigens from responses to classical TD antigens. These are the production 
mainly of IgM during the primary response (1-4, 7, 8), and the inability of such 
antigens to prime for IgG memory responses (2, 5-8, 23, 24). Whether a similar 
explanation may exist for the inability of other type 2 antigens to elicit or prime 
for IgG responses is not known. However, other type 2 antigens, such as $3 (25- 
27) and $6  (G.  Milligan,  University of Missouri,  Columbia,  MO,  unpublished 
results) are similar to PVP (15) in that all of these antigens actively interfere with 
the development and expression of IgG-producing memory B cells induced by 
TD  forms of the same antigens.  This  suggests that  all  of these antigens  may 
activate Ts that interfere with the production of IgG, although this has been 
directly demonstrated only with PVP.  Moreover, we have shown that $3  does 
not prime memory B cells, nor does it activate Th even when low (0.006  ~g) 
doses of $3 are used for priming (6 and my unpublished results). Studies are in 
progress to determine whether mice primed with $3 might have S3-specific Th 
that would be detectable if Ts were eliminated. BRALEY-MULLEN  1365 
Whether or not the observations made here with PVP will be found applicable 
to other type 2 responses, they clearly establish that a type 2 antigen is capable 
of activating Th, but that immunization with this antigen will be more likely to 
result in the predominant activation of Ts, which prevent the expression of Th 
activity needed for IgG antibody production.  Although it has previously been 
suggested (6, 8, 23) that type 2 antigens behave in this manner, this study is the 
first direct evidence supporting this hypothesis. A  major question that remains 
concerns the mechanisms involved in the induction of dominant suppression by 
type 2 antigens as compared to TD antigens, which most often induce dominant 
help, except in  some Ir gene-controlled responses, as discussed above.  These 
studies are currently in progress. 
Summary 
T cells from CAF1 mice immunized with various amounts of the type 2 antigen 
polyvinylpyrrolidone (PVP)  were assessed  for their ability to  provide  help  to 
PVP-specific memory B cells for the production of IgG. Low doses (0.0025 gg) 
of PVP consistently activated helper T  cells (Th), which were required for the 
production of IgG by primed B cells. In contrast, T  cells from mice primed with 
higher amounts (0.25 or 25 ~g) of PVP did not provide significant help to the 
same B cells for IgG production.  Moreover, when mixed with B cells and low- 
dose  PVP-primed  Th,  T  cells  from  mice primed  with  0.25  or  25  #g  PVP 
suppressed PVP-specific IgG, but not IgM antibody responses. The suppressor 
cells induced by higher amounts of PVP  were eliminated either by injecting 
cyclophosphamide (CY) before priming with PVP, or by treating the primed T 
cells with anti-Lyt-2.2 and C before transfer. Pretreatment of suppressor T  cell 
(Ts) donors with CY or removal of Lyt-2  + T  cells not only eliminated Ts activity, 
but also unmasked significant Th activity in the T  cells from high-dose PVP- 
primed mice. Thus, both low and high amounts of PVP can activate Th, although 
high amounts of PVP also induce Ts,  the activity of which predominates in a 
normal unfractionated T  cell population. The amount of PVP (0.0025 ~g) that 
induces dominant help for IgG memory responses was only marginally immu- 
nogenic for induction of primary PVP-specific IgM responses, while 0.25 and 25 
ug PVP,  which induce dominant suppression  for IgG  memory responses,  are 
optimally immunogenic for primary IgM responses. These results are discussed 
in  the context of the inability of most  type 2  antigens  to  elicit primary IgG 
responses or to prime memory B cells for production of IgG, responses which 
are dependent on the function of antigen-specific Th. 
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